| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |